Suboxone Dispenser for OUD
Withdrawn before enrolling · Not applicable
Conditions studied: Opioid Use Disorder, Opioid Withdrawal
In brief
The goal of this study is to evaluate the usability and acceptability of the Addinex system with patients receiving Suboxone in OUD treatment. The main questions it aims to answer are: * Are patients more likely to stay on their medication? * Is the risk of diversion being reduced? * How is the usability of the Addinex system for doctors and patients?
Key facts
- Study ID
- NCT05790551
- Run by
- Addinex Technologies, Inc.
- People needed
- 0
- Starts
- 2024-01-15
- Expected to finish
- 2024-08-31
- Last updated by the study team
- 2025-05-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A minimum of 18 years old at admission of study
- Primary or secondary diagnosis of opioid use disorder (DSM-5; APA, 2013) diagnosis by clinician
- Prospective patients have to select 'Yes' they are interested in Yale-approved research studies while enrolled at Aware Recovery Care and that researchers can contact them about research projects
You may not qualify if…
- Meets criterion of DSM-V (APA, 2013) for bi-polar, schizophrenia, or psychiatric disorders
- Unable to read and understand English at 5th grade level
- Unable to complete the study because of anticipated incarceration or move
- Life threatening or unstable medical problems
- Current suicide or homicide risk
- Anticipated/current pregnancy, or breastfeeding
Where it is running
- Greenwich Hospital — Greenwich, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.